Ambrosia Biosciences is aiming to move the market beyond peptide-based obesity treatments and initiate a trial for its oral ...

A team of researchers from NYU Abu Dhabi and the University of Denver have identified a promising small molecule that could ...

Platform screens up to 10 billion compounds in hours, delivering wet-lab-ready candidates in weeks without requiring 3D ...

Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, ...

Colorado drugmaker Ambrosia Biosciences has landed $100 million to pursue an oral obesity drug it’s hoping can compete with a ...

Ambrosia Biosciences. The financing provides $100 million in committed capital, intended to fund the Company through clinical ...

In a new study, researchers have identified a way to stop cells from dying, opening the door to developing treatments that slow the progression of neurodegenerative conditions like Parkinson’s disease ...

Researchers at Washington University School of Medicine in St. Louis have shown that a small chemical compound can restore ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ...

Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug, a "protein ...

Ribonucleic acids (RNAs) serve as messengers between DNA and protein production, and perform a wide variety of regulatory functions across different cellular processes. This makes them an interesting ...